Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age

British Medical Journal

Volumn 312, Issue 7042, 1996, Pages 1321-1325

  Briggs, A H ^a   Sculpher, M J ^a   Logan, R P H ^b   Aldous, J ^c   Ramsay, M E ^c   Baron, J H ^d  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE;

ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; SCREENING; SERODIAGNOSIS;

EID: 0029892658     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7042.1321     Document Type: Article

References (36)

1. Veldhuyzen van Zanten SJO, Sherman PM. Indications for treatment of Helicobacter pylori infection: a systematic overview. Can Med Assoc J 1994;150:189-98.
2. Labenz J, Börsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
3. Bell GD, Powell KU, Bolton G, Richardson PDI. Clinical and pharmacoeconomic evaluation of management strategies for duodenal ulcer disease. British Journal of Medical Economics 1993;6:45-58.
4. Campbell LM. The role of a Helicobacter pylori eradication regimen (omeprazole plus amoxycillin) in the long-term management of ulcer-like dyspepsia in general practice. British Journal of Medical Economics 1994; 7:147-53.
5. Sonnenberg A, Townsend WF, Miller AD. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches. European Journal of Gastroenterology and Hepatology 1995; 7:655-9.
6. Edenholm M, Gustavsson R, Jansson O, Lingfors H, Nilsson O, Söderlind T, et al. Endoscopic findings in patients with ulcer-like dyspepsia. Scand J Gastroenterol 1985;20:163-7.
7. Aldous J, Pryce D, Ramsay M. A pilot study of the effects of breath test screening and eradication of Helicobacter pylori on the management of dyspepsia in primary care. London: Academic Department of Public Health, St Mary's Hospital Medical School, 1994.
8. Forrester E. Alternative advice on dyspepsia treatment. Gastroenterology in Practice 1994 Feb/Mar:6-7.
9. Moore RA. Helicobacter pylon and peptic ulcer. Oxford: Health Technology Evaluation Association, 1995.
10. Clausen MR, Franzmann MB, Holst C, Sørenson TIA, Christofferson P, Matzen P, et al. Longitudinal study of influence of Helicobacter pylori on current risk of duodenal ulcer relapse. Scand J Gastroenterol 1992; 27:421-6.
11. Axon ATR, Bell GD, Jones RH, Quine MA, McCloy RF. Guidelines on appropriate indications for upper gastrointestinal endoscopy. BMJ 1995;310:853-6.
12. National Institutes of Health (NIH) Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
13. Gribble EJ. The economics of a bug-free system. Gastroenterology International 1994;7:90.
14. TreeAge Software. DATA v2.6. Boston: Treeware Software, 1995.
15. Novell. Quattro Pro v6.0. Utah: Novello, 1995.
16. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:411-58.
17. Sonnenberg FA, Beck R. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38.
18. Katz KD, Hollander D. Practical pharmacology and cost-effective management of peptic ulcer disease. Am J Surg 1992;163:349-58.
19. Bardhan D. Refractory duodenal ulcer. Gut 1984;25:711-7.
20. 13C-urea breath test. In: Rathbone BJ, Heatley RV, eds. Helicobacier pylori and gastroduodenal disease. 2nd ed. Oxford: Blackwell, 1992:88-106.
21. Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994;34:723-5.
22. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, et al. Relationship between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994;308:750-3.
23. Kemmer TP, Dominguez-Muñoz JE, Klingel H, Zemmler T, Kuhn K, Malfertheiner P. The association between non-ulcer dyspepsia and Helicobacter pylori infection. European Journal of Gastroenterology and Hepatology 1994;6:571-7.
24. HM Treasury. Economic appraisal in central government: a technical guide for government departments. London: HMSO, 1991.
25. Briggs AH, Sculpher MJ, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104.
26. Patel P, Mendall M, Khulusi S, Mollineaux N, Levy J, Maxwell JD, et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 1994;344:511-4.
27. Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;338:94-6.
28. Hastings L, Bell GD, Powell KU, Bolton C, Brown C, Sillis AJ, et al. Preliminary report on the impact of the Suffolk GP based Helicobacter pylori programme on the prescribing of ulcer healing drugs (UHDs) in general practice. Gut 1995;37(suppl 2):A6.
29. Pym B, Sanstad J, Seville P, Byth K, Middleton WRJ, Talley NJ, et al. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology 1990;99:27-35.
30. Bell GD, Powell KU, Bolton G, Richardson PDI. Reinfection of recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993(b);86:375-82.
31. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacology and Therapeutics 1994;8:359-68.
32. Duggan AE, Knifton A, Logan RPH, Hawkey CJ, Logan RFA. Validation of two new rapid blood tests for H pylori. Gut 1995;37:A58[Abstract].
33. Netten A. Unit costs of community care. Canterbury: PSSRU, University of Kent, 1994.
34. Chartered Institute of Public Finance and Accountancy. Health database: health service trends. Vol 2. Detailed tables. London: Health Service Management Association, 1990.
35. Working Party of the Clinical Services Committee of the British Society of Gastroenterology. Provision of gastrointestinal endoscopy and related services for a district general hospital. Gut 1991;32:95-105.
36. British Medical Association, Royal Pharmacological Society of Great Britain. British National Formulary. London: BMA Publishing, Royal Pharmacological Society of Great Britain, 1995.